TY - JOUR
T1 - The abnormal expression of retinoic acid receptor-β, p53 and Ki67 protein in normal, premalignant and malignant esophageal tissues
AU - Xu, Min
AU - Jin, Yu Lan
AU - Fu, Jun
AU - Huang, Hong
AU - Chen, Sheng Zu
AU - Qu, Ping
AU - Tian, Hai Mei
AU - Liu, Zhao Yang
AU - Zhang, Wei
PY - 2002
Y1 - 2002
N2 - Aim: Esophageal cancer remains a significant health problem worldwide. It is important to investigate alterations in expression of retinoic acid receptor-β, p53 and Ki67 proteins in esophageal carcinogenesis. Methods: To find biomarkers for early identification of esophageal cancer, we analyzed the retinoic acid receptor-β, p53 protein and the proliferation marker Ki67 in surgical specimens of normal, mildly, and severely dysplastic and malignant esophageal tissues by in situ hybridization of RNA and immunohistochemistry. Results: RAR-β was expressed in 94.3% (33/35) of normal mucosae, 67.8% (19/28) of the mild, 58.1% (18/31) of the severe lesions and 53.2% (116/218) of tumor samples. RAR-β mRNA was expressed in 62.7% (42/67), 55.1% (43/78) and 29.2% (7/24) of well, moderated and poorly differentiated SSCs. The p53 and Ki67 proteins were 5.9% (2/34) of the normal mucosa. P53 and Ki67 stained positively in 10.7% (3/28) and 21.4% (6/28) of mild dysplasia, and 51.6% (16/31) and 58.1% (18/31) of severely dysplasia respectively. Samples from esophageal cancer showed no higher levers of p53 and Ki67 expression than seen in severely dysplastic lesions. There was significant difference of RAR-β, p53 and Ki67 expression between normal mucosa and dysplastic tissue or esophageal cancer. Conclusion: Loss of RAR-β expression and accumulation of p53 and Ki67 proteins may serve as biomarkers for early identification of esophageal cancer in the high-risk populations.
AB - Aim: Esophageal cancer remains a significant health problem worldwide. It is important to investigate alterations in expression of retinoic acid receptor-β, p53 and Ki67 proteins in esophageal carcinogenesis. Methods: To find biomarkers for early identification of esophageal cancer, we analyzed the retinoic acid receptor-β, p53 protein and the proliferation marker Ki67 in surgical specimens of normal, mildly, and severely dysplastic and malignant esophageal tissues by in situ hybridization of RNA and immunohistochemistry. Results: RAR-β was expressed in 94.3% (33/35) of normal mucosae, 67.8% (19/28) of the mild, 58.1% (18/31) of the severe lesions and 53.2% (116/218) of tumor samples. RAR-β mRNA was expressed in 62.7% (42/67), 55.1% (43/78) and 29.2% (7/24) of well, moderated and poorly differentiated SSCs. The p53 and Ki67 proteins were 5.9% (2/34) of the normal mucosa. P53 and Ki67 stained positively in 10.7% (3/28) and 21.4% (6/28) of mild dysplasia, and 51.6% (16/31) and 58.1% (18/31) of severely dysplasia respectively. Samples from esophageal cancer showed no higher levers of p53 and Ki67 expression than seen in severely dysplastic lesions. There was significant difference of RAR-β, p53 and Ki67 expression between normal mucosa and dysplastic tissue or esophageal cancer. Conclusion: Loss of RAR-β expression and accumulation of p53 and Ki67 proteins may serve as biomarkers for early identification of esophageal cancer in the high-risk populations.
UR - http://www.scopus.com/inward/record.url?scp=0036232385&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036232385&partnerID=8YFLogxK
U2 - 10.3748/wjg.v8.i2.200
DO - 10.3748/wjg.v8.i2.200
M3 - Article
C2 - 11925591
AN - SCOPUS:0036232385
SN - 1007-9327
VL - 8
SP - 200
EP - 202
JO - World Journal of Gastroenterology
JF - World Journal of Gastroenterology
IS - 2
ER -